Skip to content
RDL Network logo
Mineralocorticoid Receptor Antagonist Use in Hospitalized Patients With Heart Failure, Reduced Ejection Fraction, and Diabetes Mellitus (from the EVEREST Trial) — Muthiah Vaduganathan (2014) | RDL Network